Safeguard scientifics inc (SFE)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
Cash Flows from Operating Activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

54,561

-15,629

-88,572

-22,262

-59,524

-5,149

-35,525

-39,362

110,597

26,609

68,773

Adjustments to reconcile to net cash used in operating activities:
(Income) loss from discontinued operations

-

-

-

-

-

-

-

-

-

-

1,975

Depreciation

808

692

322

328

190

74

92

108

124

121

1,425

Amortization of debt discount

3,454

4,513

2,542

1,604

1,472

1,349

995

726

623

426

-

Amortization of right of use asset

260

-

-

-

-

-

-

-

-

-

-

Income (Loss) from Equity Method Investments

64,267

19,661

-66,358

671

-39,599

-15,335

-12,607

-26,517

142,457

-22,334

-23,227

(Income) loss from change in fair value of derivative

5,060

-4,541

0

-

-

-

-

-

-

-

-

Gain from observable price changes

4,526

1,415

0

-

-

-

-

-

-

-

-

Other, net

2,268

-2,044

-339

-

-

-

-

-

-

-

-

Loss on sale of property and equipment

-

-

0

-

-

-

-

-

-

-

-

Other (income) loss, net

-

-

-

-1,682

217

31,657

383

9,338

-6,145

74,809

108,881

Bad debt expense

-

-

-

-

-

-

-

-

-

-

3,936

Stock-based compensation, including liability classified awards

1,237

966

1,138

2,394

1,611

1,935

1,821

2,014

3,052

3,777

3,825

Changes in assets and liabilities:
Prepaid expenses and other current assets

823

2,065

3,560

1,521

923

369

1,194

418

429

195

11,467

Accounts payable, accrued expenses, and other

-3,346

-21

628

-215

43

-1,707

366

3,228

4,618

5,718

1,967

Net cash used in operating activities

-19,970

-26,035

-20,805

-18,661

-17,749

-20,189

-21,221

-16,525

-17,727

-16,019

-19,170

Cash Flows from Investing Activities:
Proceeds from sales of and distributions from ownership interests

104,302

67,387

16,604

73,965

25,058

82,822

38,974

17,596

171,268

183,813

61,302

Acquisitions of ownership interest

11,640

3,250

15,101

52,431

70,186

59,476

41,838

46,100

85,329

20,418

35,939

Advances and loans

5,055

13,104

22,867

27,967

15,208

10,968

10,464

13,665

12,127

11,710

1,350

Repayment of advances and loans

750

10,730

0

1,741

1,318

4,684

1,651

3,214

5,000

2,009

5,679

Origination fees on mezzanine loans

-

-

-

-

-

-

-

-

537

-

-

Purchases of marketable securities

57,243

37,809

0

21,194

29,755

55,594

69,883

242,023

240,367

65,201

73,187

Proceeds from sales and maturities in marketable securities

95,189

8,148

11,237

46,315

33,640

55,410

165,379

276,392

108,393

61,856

48,822

Proceeds from sales of property and equipment

0

1

0

-

-

-

-

-

-

-

-

Release of restricted cash equivalents for interest on convertible senior debentures

-

-

-

-

-

-

-

-7,701

0

-

1,956

Investment in restricted cash equivalents for interest on convertible senior debentures

-

-

-

-

-

-

-

-

-

18,864

-

Capital expenditures

-

-

-

432

1,856

59

37

73

58

106

2,157

Deconsolidation of subsidary cash

-

-

-

-

-

-

-

-

-

-

2,667

Proceeds from sale of discontinued operations, net

-

-

-

-

-

-

6,434

0

1

477

1,500

Other, net

-

-

-

-64

0

-137

-42

-74

-107

-

-

Net cash (used in) provided by investing activities

126,303

32,103

-10,127

20,061

-56,989

16,956

90,258

3,116

-52,575

131,856

47

Cash Flows from Financing Activities:
Payment of dividend

20,679

0

-

-

-

-

-

-

-

-

-

Proceeds from credit facility

0

35,000

50,000

0

0

-

-

-

-

-

-

Issuance costs of credit facility

0

2,252

5,696

0

0

-

-

1,790

0

872

-

Repayments of Lines of Credit

68,568

16,433

0

-

-

-

-

-

-

-

-

Proceeds from issuance of convertible senior debentures

-

-

-

-

-

-

-

55,000

0

-

-

Repurchase of convertible senior debentures

0

41,000

14,455

0

0

441

43

58,703

30,848

-

7,271

Borrowings on revolving credit facilities

-

-

-

-

-

-

-

-

-

-

23,726

Repayments on revolving credit facilities

-

-

-

-

-

-

-

-

-

-

33,237

Repayments on term debt

-

-

-

-

-

-

-

-

-

-

107

Issuance of Company common stock, net

-

-

-

5

676

1,289

4,417

1,744

918

1,107

270

Tax withholdings related to equity-based awards

236

267

223

460

0

0

-

-

-

-

-

Issuance of Company common stock, net

-

-

1

-

-

-

-

-

-

-

-

Issuance of subsidiary equity, net

-

-

-

-

-

-

-

-

-

-

28,082

Repurchase of Company common stock

-

-

-

5,389

4,997

25,036

122

0

0

-

44

Net cash used in financing activities

-89,483

-24,952

29,625

-5,844

-4,321

-24,188

4,252

-3,749

-29,930

235

11,419

Net change in cash, cash equivalents and restricted cash

16,850

-18,884

-1,307

-4,444

-79,059

-

-

-

-

-

-

Net change in cash, cash equivalents and restricted cash equivalents

16,850

-18,884

-1,307

-4,444

-79,059

-27,421

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

73,289

-17,158

-100,232

116,072

-7,704